CSS LLC’s Novartis NVS Stock Holding History

CSS LLC’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,620	Closed	-$223K	–	1129
2025 Q4	$223K	Buy	+1,620	New	+$212K	0.01%	753
2016 Q1	–	Sell	-2,609	Closed	-$201K	–	712
2015 Q4	$201K	Hold	2,609	–	–	0.01%	561
2015 Q3	$215K	Hold	2,609	–	–	0.01%	568
2015 Q2	$230K	Hold	2,609	–	–	0.01%	631
2015 Q1	$231K	Hold	2,609	–	–	0.01%	583
2014 Q4	$217K	Hold	2,609	–	–	0.01%	624
2014 Q3	$220K	Hold	2,609	–	–	0.01%	646
2014 Q2	$212K	Buy	+2,609	New	+$205K	0.01%	635

Other funds holding NVS

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CSS LLC's NVS Position: Q1 2026 in Review

CSS LLC sold out of Novartis (NVS) in Q1 2026, closing a stake of 1,620 shares — an estimated $223K sold.

CSS LLC first reported a position in NVS in Q2 2014 and held it in 8 quarters. The position peaked at $231K in Q1 2015. 1,601 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

CSS LLC reported no remaining Novartis position as of Q1 2026 after selling out during the quarter.
CSS LLC sold 1,620 Novartis shares in Q1 2026, an estimated $223K.
CSS LLC first reported a position in Novartis in Q2 2014 and held it in 8 quarters.
CSS LLC's Novartis position peaked at $231K in Q1 2015.
1,601 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on CSS LLC's 13F filing for Q1 2026, filed 15 May 2026.